Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4962426, 6 pages
https://doi.org/10.1155/2017/4962426
Review Article

MiR-222 in Cardiovascular Diseases: Physiology and Pathology

Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of Nantong University, Nantong 226001, China

Correspondence should be addressed to Chongjun Zhong; moc.621@100tnjcgnohz

Received 6 October 2016; Revised 7 December 2016; Accepted 13 December 2016; Published 3 January 2017

Academic Editor: Xinli Li

Copyright © 2017 Shengguang Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Moran, D. Gu, D. Zhao et al., “Future cardiovascular disease in China markov model and risk factor scenario projections from the coronary heart disease policy model-China,” Circulation, vol. 3, no. 3, pp. 243–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Vimalraj and N. Selvamurugan, “MicroRNAs expression and their regulatory networks during mesenchymal stem cells differentiation toward osteoblasts,” International Journal of Biological Macromolecules, vol. 66, pp. 194–202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Lee, R. L. Feinbaum, and V. Ambros, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Wu, “Plant microRNAs and development,” Journal of Genetics and Genomics, vol. 40, no. 5, pp. 217–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Qian, Z. Zhang, J. Liang et al., “The full-length transcripts and promoter analysis of intergenic microRNAs in Drosophila melanogaster,” Genomics, vol. 97, no. 5, pp. 294–303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Quach, L. B. Barreiro, G. Laval et al., “Signatures of purifying and local positive selection in human miRNAs,” American Journal of Human Genetics, vol. 84, no. 3, pp. 316–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Bentwich, A. Avniel, Y. Karov et al., “Identification of hundreds of conserved and nonconserved human microRNAs,” Nature Genetics, vol. 37, no. 7, pp. 766–770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Van Rooij, L. B. Sutherland, N. Liu et al., “A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18255–18260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Volinia, G. A. Calin, C.-G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Zhang, J. Zhang, A. Zhang et al., “PUMA is a novel target of miR-221/222 in human epithelial cancers,” International Journal of Oncology, vol. 37, no. 6, pp. 1621–1626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Le Sage, R. Nagel, D. A. Egan et al., “Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation,” EMBO Journal, vol. 26, no. 15, pp. 3699–3708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Visone, L. Russo, P. Pallante et al., “MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle,” Endocrine-Related Cancer, vol. 14, no. 3, pp. 791–798, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. E. Miller, K. Ghoshal, B. Ramaswamy et al., “MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1,” Journal of Biological Chemistry, vol. 283, no. 44, pp. 29897–29903, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Fu, Q. Wang, J. Chen et al., “Clinical significance of miR-221 and its inverse correlation with p27 Kip1 in hepatocellular carcinoma,” Molecular Biology Reports, vol. 38, no. 5, pp. 3029–3035, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Garofalo, C. Quintavalle, G. Di Leva et al., “MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer,” Oncogene, vol. 27, no. 27, pp. 3845–3855, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Tao, Y. Bei, H. Zhang, J. Xiao, and X. Li, “Exercise for the heart: signaling pathways,” Oncotarget, vol. 6, no. 25, pp. 20773–20784, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Liu, J. Xiao, H. Zhu et al., “MiR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling,” Cell Metabolism, vol. 21, no. 4, pp. 584–595, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. D. S. Lee, J.-H. Chen, D. J. Lundy et al., “Defined microRNAs induce aspects of maturation in mouse and human embryonic-stem-cell-derived cardiomyocytes,” Cell Reports, vol. 12, no. 12, pp. 1960–1967, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Su, Z. Chen, C. Wang et al., “Cardiac-specific overexpression of miR-222 induces heart failure and inhibits autophagy in mice,” Cellular Physiology and Biochemistry, vol. 39, no. 4, pp. 1503–1511, 2016. View at Publisher · View at Google Scholar
  20. D. Li, L. Ji, L. Liu et al., “Characterization of circulating microRNA expression in patients with a ventricular septal defect,” PLoS ONE, vol. 9, no. 8, Article ID e106318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Riedel, S. Radzanowski, T. S. Bowen et al., “Exercise training improves high-density lipoprotein-mediated transcription of proangiogenic microRNA in endothelial cells,” European Journal of Preventive Cardiology, vol. 22, no. 7, pp. 899–903, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Duan, H. Yao, G. Hu, X. Chen, A. K. Lund, and S. Buch, “HIV tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy,” PLoS ONE, vol. 8, no. 3, Article ID e60170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Corsten, W. Heggermont, A.-P. Papageorgiou et al., “The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis,” European Heart Journal, vol. 36, no. 42, pp. 2909–2919, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H. A. Bazan, S. A. Hatfield, C. B. O'Malley, A. J. Brooks, D. Lightell, and T. C. Woods, “Acute loss of miR-221 and miR-222 in the atherosclerotic plaque shoulder accompanies plaque rupture,” Stroke, vol. 46, no. 11, pp. 3285–3287, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Zhang, J.-J. Chang, F. Xu et al., “MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot,” Canadian Journal of Cardiology, vol. 29, no. 12, pp. 1695–1703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Togliatto, A. Trombetta, P. Dentelli et al., “Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression,” Journal of the American Heart Association, vol. 2, no. 6, p. e000376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Zahedi, M. Nazari-Jahantigh, Z. Zhou et al., “Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair,” Cellular and Molecular Life Sciences, 2016. View at Publisher · View at Google Scholar
  28. E. D. Abel and T. Doenst, “Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy,” Cardiovascular Research, vol. 90, no. 2, pp. 234–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., “Evidence for cardiomyocyte renewal in humans,” Science, vol. 324, no. 5923, pp. 98–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. A. Kocher, B. Schlechta, A. Gasparovicova, E. Wolner, N. Bonaros, and G. Laufer, “Stem cells and cardiac regeneration,” Transplant International, vol. 20, no. 9, pp. 731–746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Dentelli, A. Rosso, F. Orso, C. Olgasi, D. Taverna, and M. F. Brizzi, “MicroRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1562–1568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. de Gonzalo-Calvo, A. Cenarro, F. Civeira, and V. Llorente-Cortes, “microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers,” Clinica e Investigacion en Arteriosclerosis, vol. 28, pp. 167–177, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. B. C. Bernardo, X.-M. Gao, C. E. Winbanks et al., “Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, pp. 17615–17620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Tanasescu, M. F. Leitzmann, E. B. Rimm, W. C. Willett, M. J. Stampfer, and F. B. Hu, “Exercise type and intensity in relation to coronary heart disease in men,” Journal of the American Medical Association, vol. 288, no. 16, pp. 1994–2000, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Evangelista, A. M. Deschamps, D. Liu, N. Raghavachari, and E. Murphy, “miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1,” Physiological Genomics, vol. 45, no. 12, pp. 493–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhang, B. Wang, X. Fu et al., “Exogenous NAD+ administration significantly protects against myocardial ischemia/reperfusion injury in rat model,” American Journal of Translational Research, vol. 8, no. 8, pp. 3342–3350, 2016. View at Google Scholar · View at Scopus
  37. F. Bagheri, V. Khori, A. M. Alizadeh, S. Khalighfard, S. Khodayari, and H. Khodayari, “Reactive oxygen species-mediated cardiac-reperfusion injury: mechanisms and therapies,” Life Sciences, vol. 165, pp. 43–55, 2016. View at Publisher · View at Google Scholar
  38. X. Huang, L. Zuo, Y. Lv et al., “Asiatic acid attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β/HIF-1α signaling in rat H9c2 cardiomyocytes,” Molecules, vol. 21, no. 9, article 1248, 2016. View at Publisher · View at Google Scholar
  39. F. P. Hans, M. Moser, C. Bode, and S. Grundmann, “MicroRNA regulation of angiogenesis and arteriogenesis,” Trends in Cardiovascular Medicine, vol. 20, no. 8, pp. 253–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Barbaro and S. E. Lipshultz, “Pathogenesis of HIV-associated cardiomyopathy,” Annals of the New York Academy of Sciences, vol. 946, pp. 57–81, 2001. View at Google Scholar · View at Scopus
  41. G. Hu, A.-Y. Gong, J. Liu, R. Zhou, C. Deng, and X.-M. Chen, “miR-221 suppresses ICAM-1 translation and regulates interferon-γ-induced ICAM-1 expression in human cholangiocytes,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 298, no. 4, pp. G542–G550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J. P. Starr, “Tetralogy of fallot: yesterday and today,” World Journal of Surgery, vol. 34, no. 4, pp. 658–668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Hergenreider, S. Heydt, K. Tréguer et al., “Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs,” Nature Cell Biology, vol. 14, no. 3, pp. 249–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Jansen, X. Yang, S. Proebsting et al., “MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease,” Journal of the American Heart Association, vol. 3, no. 6, Article ID 001249, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Liu, Y. Cheng, S. Zhang, Y. Lin, J. Yang, and C. Zhang, “A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia,” Circulation Research, vol. 104, no. 4, pp. 476–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Liu, Y. Cheng, J. Yang, L. Xu, and C. Zhang, “Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 1, pp. 245–255, 2012. View at Publisher · View at Google Scholar · View at Scopus